GPT Healthcare credit ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024
16.116.113.312.4
−31.3−31.3−23.0−7.9
0.06×0.06×0.05×0.06×
−0.12×−0.12×−0.09×−0.04×
0.19×0.19×0.16×0.14×
−0.34×−0.37×−0.28×−0.09×
6.93×6.93×18.53×9.83×
5.6%5.6%5.1%5.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

GPTHEALTH₹136.89

GPT Healthcare Limited

· Pharma & Health
₹ CrorePeersGKSLSHALBYINDRAMEDCOLOTUSEYEARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹1,123 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt12.413.316.116.1
Net Debt-7.9-23.0-31.3-31.3
Total Debt/Equity0.060.050.060.06
Net Debt/Equity-0.04-0.09-0.12-0.12
Total Debt/EBITDA0.140.160.190.19
Net Debt/EBITDA-0.09-0.28-0.37-0.34
Interest Coverage (EBIT/Interest)9.8318.536.936.93
Total Debt/Total Capital %5.385.095.645.64
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.